Literature DB >> 16673021

Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRbeta locus rearrangements and putative new T-cell oncogenes.

B Cauwelier1, N Dastugue, J Cools, B Poppe, C Herens, A De Paepe, A Hagemeijer, F Speleman.   

Abstract

Chromosomal aberrations of T-cell receptor (TCR) gene loci often involve the TCRalphadelta (14q11) locus and affect various known T-cell oncogenes. A systematic fluorescent in situ hybridization (FISH) screening for the detection of chromosomal aberrations involving the TCR loci, TCRalphadelta (14q11), TCRbeta (7q34) and TCRgamma (7p14), has not been conducted so far. Therefore, we initiated a screening of 126 T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma cases and 19 T-ALL cell lines using FISH break-apart assays for the different TCR loci. Genomic rearrangements of the TCRbeta locus were detected in 24/126 cases (19%), most of which (58.3%) were not detected upon banding analysis. Breakpoints in the TCRalphadelta locus were detected in 22/126 cases (17.4%), whereas standard cytogenetics only detected 14 of these 22 cases. Cryptic TCRalphadelta/TCRbeta chromosome aberrations were thus observed in 22 of 126 cases (17.4%). Some of these chromosome aberrations target new putative T-cell oncogenes at chromosome 11q24, 20p12 and 6q22. Five patients and one cell line carried chromosomal rearrangements affecting both TCRbeta and TCRalphadelta loci. In conclusion, this study presents the first inventory of chromosomal rearrangements of TCR loci in T-ALL, revealing an unexpected high number of cryptic chromosomal rearrangements of the TCRbeta locus and further broadening the spectrum of genes putatively implicated in T-cell oncogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16673021     DOI: 10.1038/sj.leu.2404243

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  22 in total

1.  The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.

Authors:  Rebecca L Boddicker; N Sertac Kip; Xiaoming Xing; Yu Zeng; Zhi-Zhang Yang; Jeong-Heon Lee; Luciana L Almada; Sherine F Elsawa; Ryan A Knudson; Mark E Law; Rhett P Ketterling; Julie M Cunningham; Yanhong Wu; Matthew J Maurer; Megan M O'Byrne; James R Cerhan; Susan L Slager; Brian K Link; Julie C Porcher; Deanna M Grote; Diane F Jelinek; Ahmet Dogan; Stephen M Ansell; Martin E Fernandez-Zapico; Andrew L Feldman
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

Review 2.  T-cell acute lymphoblastic leukemia.

Authors:  Sabina Chiaretti; Robin Foà
Journal:  Haematologica       Date:  2009-02       Impact factor: 9.941

Review 3.  The effect of TLX3 expression on the prognosis of pediatric T cell acute lymphocytic leukemia--a systematic review.

Authors:  Jiexian Ma; Jinsheng Hua; Yinghao Sha; Yanhui Xie
Journal:  Tumour Biol       Date:  2014-07-06

Review 4.  The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.

Authors:  Olga Lancho; Daniel Herranz
Journal:  Trends Cancer       Date:  2018-11-02

5.  New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461.

Authors:  Alison Walker; Krzysztof Mrózek; Jessica Kohlschmidt; Kathleen W Rao; Mark J Pettenati; Lisa J Sterling; Guido Marcucci; Andrew J Carroll; Clara D Bloomfield
Journal:  Genes Chromosomes Cancer       Date:  2012-12-10       Impact factor: 5.006

Review 6.  The role of enhancers in cancer.

Authors:  Inderpreet Sur; Jussi Taipale
Journal:  Nat Rev Cancer       Date:  2016-07-01       Impact factor: 60.716

7.  Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group.

Authors:  Kristi J Smock; Marilu Nelson; Sheryl R Tripp; Warren G Sanger; Minnie Abromowitch; Mitchell S Cairo; Sherrie L Perkins
Journal:  Pediatr Blood Cancer       Date:  2008-10       Impact factor: 3.167

8.  An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

Authors:  Jonathan Bond; Tony Marchand; Aurore Touzart; Agata Cieslak; Amélie Trinquand; Laurent Sutton; Isabelle Radford-Weiss; Ludovic Lhermitte; Salvatore Spicuglia; Hervé Dombret; Elizabeth Macintyre; Norbert Ifrah; Jean-François Hamel; Vahid Asnafi
Journal:  Haematologica       Date:  2016-03-04       Impact factor: 9.941

9.  Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults.

Authors:  Paolo Gorello; Roberta La Starza; Emanuela Varasano; Sabina Chiaretti; Loredana Elia; Valentina Pierini; Gianluca Barba; Lucia Brandimarte; Barbara Crescenzi; Antonella Vitale; Monica Messina; Sara Grammatico; Marco Mancini; Caterina Matteucci; Antonella Bardi; Anna Guarini; Massimo Fabrizio Martelli; Robin Foà; Cristina Mecucci
Journal:  Haematologica       Date:  2010-01       Impact factor: 9.941

10.  Genetic and epigenetic determinants mediate proneness of oncogene breakpoint sites for involvement in TCR translocations.

Authors:  N S D Larmonie; A van der Spek; A J J C Bogers; J J M van Dongen; A W Langerak
Journal:  Genes Immun       Date:  2013-12-05       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.